1. Home
  2. CFND vs CPIX Comparison

CFND vs CPIX Comparison

Compare CFND & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CFND

C1 Fund Inc.

N/A

Current Price

$5.36

Market Cap

36.5M

Sector

N/A

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$2.39

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFND
CPIX
Founded
N/A
1999
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
34.1M
IPO Year
2025
2009

Fundamental Metrics

Financial Performance
Metric
CFND
CPIX
Price
$5.36
$2.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
72.1K
Earning Date
N/A
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,278,349.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.21
52 Week Low
N/A
$1.09
52 Week High
N/A
$7.25

Technical Indicators

Market Signals
Indicator
CFND
CPIX
Relative Strength Index (RSI) N/A 50.86
Support Level N/A $2.11
Resistance Level N/A $2.39
Average True Range (ATR) 0.00 0.19
MACD 0.00 0.08
Stochastic Oscillator 0.00 72.00

Price Performance

Historical Comparison
CFND
CPIX

About CFND C1 Fund Inc.

C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: